Advancements in Chitosan-Based Nanoparticles for Pulmonary Drug Delivery

The evolution of respiratory diseases represents a considerable public health challenge, as they are among the leading causes of death worldwide. In this sense, in addition to the high prevalence of diseases such as asthma, chronic obstructive pulmonary disease, pneumonia, cystic fibrosis, and lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Zacaron, Thiago Medeiros, Silva, Mariana Leite Simões e, Costa, Mirsiane Pascoal, Silva, Dominique Mesquita e, Silva, Allana Carvalho, Apolônio, Ana Carolina Morais, Fabri, Rodrigo Luiz, Pittella, Frederico, Rocha, Helvécio Vinícius Antunes, Tavares, Guilherme Diniz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536410/
https://www.ncbi.nlm.nih.gov/pubmed/37765701
http://dx.doi.org/10.3390/polym15183849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536410/
https://www.ncbi.nlm.nih.gov/pubmed/37765701
http://dx.doi.org/10.3390/polym15183849

Ejemplares similares